Literature DB >> 9209705

PPAR gamma and the control of adipogenesis.

B M Spiegelman1, E Hu, J B Kim, R Brun.   

Abstract

We recently cloned PPAR gamma as a factor that binds to an enhancer which has specificity for adipose cells. When expressed ectopically, PPAR gamma converts fibroblasts into bona fide preadipose cells. Upon application of activators or PPAR gamma ligands, these cells differentiate into fat cells. Most recently, we have been trying to understand the nature of natural ligands that activate PPAR gamma and the protein domains that control adipogenesis. With regards to ligands, we have shown that an unusual prostanoid, 15-deoxy delta 12,14PG J2, can bind to PPAR gamma and activate it. A second transcription factor that is induced early in differentiation, ADD1/SREBP1, appears to promote the formation of PPAR gamma ligands. Transfection of this molecule, a member of the bHLH family, causes the secretion of molecules that can serve as ligands for PPAR gamma. This ligand-like activity is specific for the gamma isoform of PPAR. Current studies are attempting to identify these potentially novel ligands. With regard to structure-function of PPAR gamma, we first analyzed the adipogenic activity of the three isoforms of PPAR: alpha, gamma and delta. Using appropriate activators of each it is clear that PPAR gamma has the most adipogenic action. PPAR alpha can be adipogenic with high levels of the strongest activators and PPAR delta does not stimulate fat cell differentiation. To identify the domain(s) of PPAR gamma responsible for differentiation, chimeras between PPAR gamma and PPAR delta were created and transfected into fibroblasts. This has allowed the isolation of relatively small regions of this molecule that are responsible for differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209705     DOI: 10.1016/s0300-9084(97)81500-3

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  45 in total

Review 1.  Significance of anti-inflammatory effects of PPARgamma agonists?

Authors:  G Rogler
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

2.  Blockade of adipocyte differentiation by cordycepin.

Authors:  Shuhei Takahashi; Minori Tamai; Shotaro Nakajima; Hironori Kato; Hisashi Johno; Tomoyuki Nakamura; Masanori Kitamura
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

3.  IFATS collection: Stem cell antigen-1-positive ear mesenchymal stem cells display enhanced adipogenic potential.

Authors:  Jaroslaw Staszkiewicz; Jeffrey M Gimble; Jessica A Manuel; Barbara Gawronska-Kozak
Journal:  Stem Cells       Date:  2008-07-03       Impact factor: 6.277

4.  Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.

Authors:  Taro E Akiyama; Shuichi Sakai; Gilles Lambert; Christopher J Nicol; Kimihiko Matsusue; Satish Pimprale; Ying-Hue Lee; Mercedes Ricote; Christopher K Glass; H Bryan Brewer; Frank J Gonzalez
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages.

Authors:  Marilena Ciciarello; Roberta Zini; Lara Rossi; Valentina Salvestrini; Davide Ferrari; Rossella Manfredini; Roberto M Lemoli
Journal:  Stem Cells Dev       Date:  2012-12-21       Impact factor: 3.272

6.  Heritability of fat accumulation in white adipocytes.

Authors:  Liora S Katz; Elizabeth Geras-Raaka; Marvin C Gershengorn
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-17       Impact factor: 4.310

7.  Adipogenesis and epicardial adipose tissue: a novel fate of the epicardium induced by mesenchymal transformation and PPARγ activation.

Authors:  Yukiko Yamaguchi; Susana Cavallero; Michaela Patterson; Hua Shen; Jian Xu; S Ram Kumar; Henry M Sucov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

8.  Peroxisome proliferator-activated receptors in diabetic nephropathy.

Authors:  Shinji Kume; Takashi Uzu; Keiji Isshiki; Daisuke Koya
Journal:  PPAR Res       Date:  2009-03-04       Impact factor: 4.964

9.  Single nucleotide polymorphisms in obesity-related genes and all-cause and cause-specific mortality: a prospective cohort study.

Authors:  Lisa Gallicchio; Howard H Chang; Dana K Christo; Lucy Thuita; Han Yao Huang; Paul Strickland; Ingo Ruczinski; Sandra Clipp; Kathy J Helzlsouer
Journal:  BMC Med Genet       Date:  2009-10-09       Impact factor: 2.103

10.  Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1.

Authors:  Jennifer C Carter; Frank C Church
Journal:  PPAR Res       Date:  2009-08-06       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.